Trends & Forecasts

What lies ahead for the future of pharma? Dennis van Rooji gives his view.

Accelerating the progress of cell and gene therapies with decentralized trials and other innovative approaches.

AI helps make preclinical decisions faster, but stakeholders remain cautious. We asked an expert from Elsevier for their views on the challenges.

New medicines save lives, but they take too long to get to market. Could AI make a difference?

Cell and Gene therapies have come a long way since the 1970s. Technology, combined with knowledge, will take them even further.

Jon Thomas, CEO of CIRM, discusses the evolution of stem cell research and the future of regenerative medicine in this interview.

Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

Celebrate a decade of pharma innovation with The Medicine Maker’s top features, from cancer vaccines to CRISPR breakthroughs.

As 2024 draws to its conclusion, two experts look at trends in clinical trials and form predictions for 2025.